See MRI-Targeted Fusion Biopsy in Action with
UC-CARE at AUA 2026
May 15–18, 2026
Walter E. Washington Convention Center
Washington, DC | Booth #719
Now’s the Time to Bring MRI-Fusion to Your Practice
New 2026 prostate CPT® codes heavily favor MRI-targeted fusion biopsy, putting more pressure on practices to bring fusion into your office, ASC or hospital practice quickly and efficiently.
Visit UC-CARE at Booth 719 at AUA 2026 to learn how…
-
Affordable and easy MRI-fusion biopsy can be with the Navigo 4D Fusion and SmartBx Biopsy systems.
-
TP or TRUS fusion biopsies can be implemented to optimize efficiency, reimbursement, and patient care.
-
Flexible purchase options can make MRI-fusion biopsies profitable from the start.
Get ahead of the crowd and schedule your live Navigo + SmartBx demo or just connect with us to learn more.
Accurate.
-
MotionLock™ self-corrects for patient motion
-
MRI guidance 2-3x more sensitive
Automated. Adaptable.
-
Automated biopsy marking without pedal or button
-
Side-fire and End-fire
-
Transrectal and Transperineal
Affordable.
-
Works with your ultrasound
-
Practice profitability from the start
Unparalleled Documentation.
-
Marks every single biopsy
-
Prior biopsy procedure comparison
-
Integrated treatment planning
-
Supports surveillance and focal therapy with pinpoint precision
Unmatched Ultrasound Compatibility.
-
SmartSync™ automatically adapts, measures, contours and marks
-
100% biopsy documentation with integrated 3D treatment planning
Demo Navigo at #AUA26
If you’re wondering what comes next for your practice, Booth 719 is the best place to start.
See how UC-CARE helps make adopting MRI-targeted fusion biopsy faster, easier, and more affordable for your practice while supporting the requirements of the new prostate billing reimbursement codes.
Don’t miss your chance to test out the technology that’s making MRI-fusion easier to adopt!
.png){kind=small}
.png){kind=small}
Copyright © 2024 UC-Care